Waste treatment method in radiopharmaceutical production process
By generating AgI crystals from DNA-silver nanocomposites with iodine-131 and combining this with vacuum evaporation and cement solidification technology, the problem of separating and solidifying iodine-131 wastewater during radiopharmaceutical production was solved, achieving efficient and safe radioactive waste treatment and reducing environmental pollution risks and treatment costs.
Patent Information
- Application Number
- CN202511511926.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-10-22
- Publication Date
- 2026-03-06
AI Technical Summary
Iodine-131 is difficult to separate effectively from wastewater generated during the production of radiopharmaceuticals, resulting in a high risk of environmental pollution. Traditional evaporation and concentration technologies are inefficient and have the problem of entrainment of volatile iodine-131.
DNA-silver nanocomposite material is used to combine with iodine-131 to generate AgI crystals. Vacuum evaporation process and cement solidification technology are used to ensure the fixation and separation of iodine-131. The condensate is tested by high-purity germanium gamma spectrometry to ensure that it meets the discharge standards. Double-layer stainless steel storage containers are used for safe storage.
It achieves efficient separation and solidification of radioactive waste, reduces the risk of environmental pollution, improves treatment efficiency, reduces water waste, and ensures the safe management and long-term storage of radioactive waste.